S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
Log in

NYSEMKT:BIOXBioceres Crop Solutions Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. The company operates in three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets adjuvants, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. In addition, the company offers HB4, a drought tolerant seed technology program. It serves clients in Argentina, Austria, Bolivia, Brazil, China, Libano, the United States, Italy, Paraguay, the United Kingdom, South Africa, France, Canada, Ukraine, Uruguay, and internationally. The company is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres S.A.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Agricultural Inputs
Sub-IndustryN/A
SectorBasic Materials
Current SymbolNYSEMKT:BIOX
CUSIPN/A
CIKN/A
Phone54 34 1486 1100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive BIOX News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOX and its competitors with MarketBeat's FREE daily newsletter.


Bioceres Crop Solutions (NYSEMKT:BIOX) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Bioceres Crop Solutions?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bioceres Crop Solutions in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Bioceres Crop Solutions.

When is Bioceres Crop Solutions' next earnings date?

Bioceres Crop Solutions is scheduled to release its next quarterly earnings announcement on Thursday, May 28th 2020. View our earnings forecast for Bioceres Crop Solutions.

Has Bioceres Crop Solutions been receiving favorable news coverage?

Press coverage about BIOX stock has been trending very negative recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Bioceres Crop Solutions earned a coverage optimism score of -3.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutBioceres Crop Solutions.

Who are some of Bioceres Crop Solutions' key competitors?

What other stocks do shareholders of Bioceres Crop Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bioceres Crop Solutions investors own include Amarin (AMRN), Crispr Therapeutics (CRSP), Moderna (MRNA), Novavax (NVAX), Arcadia Biosciences (RKDA), Arrowhead Pharmaceuticals (ARWR), ArQule (ARQL), Aquestive Therapeutics (AQST), Apellis Pharmaceuticals (APLS) and AlarmCom (ALRM).

Who are Bioceres Crop Solutions' key executives?

Bioceres Crop Solutions' management team includes the following people:
  • Mr. Federico Trucco, CEO & Exec. Director (Age 43)
  • Mr. Enrique López Lecube, CFO & Exec. Director (Age 38)
  • Mr. Jorge Wagner, Chief Operating Officer (Age 51)
  • Mr. Gerónimo Watson, Chief Technology Officer (Age 42)
  • Ms. Gloria Montaron Estrada, Gen. Counsel & Exec. Director (Age 49)

What is Bioceres Crop Solutions' stock symbol?

Bioceres Crop Solutions trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "BIOX."

How do I buy shares of Bioceres Crop Solutions?

Shares of BIOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Bioceres Crop Solutions' official website?

The official website for Bioceres Crop Solutions is http://biocerescrops.com/.

How can I contact Bioceres Crop Solutions?

The company can be reached via phone at 54 34 1486 1100.

This page was last updated on 4/8/2020 by MarketBeat.com Staff

Featured Article: Stocks Increasing Dividends

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel